National Institutes of Health (NIH)

Commercializing Diagnostics for National Security

Rockridge® supports the NIH's Rapid Acceleration of Diagnostics (RADx) program designed to develop fast, easy-to-use, and widely accessible COVID testing. Securing the U.S. economy and health infrastructure requires experienced and knowledgeable business, legal and technical leaders. We're proud that multiple members of the Rockridge team fit this bill and are formally identified as RADx Faculty. Through the RADx program, Rockridge helps evaluate and optimize the commercialization potential of applicant technologies so that the U.S. can develop a robust response to COVID and future viral outbreaks in the interest of national security.

Rockridge Venture Law® is an intellectual property, privacy and technology firm, internationally recognized for its advancement of triple-bottom-line business models and sustainable solutions to global challenges. We're Building Today's Company for Tomorrow's Economy® by leading clients through the dizzying array of information controls, by helping them to develop and monetize proprietary assets, and by enabling their impactful products, programs, and principles.

RVL® Beta:


Game-changing Biotech
Read Our Case Study